NE HEALTH BUREAU
AHMEDABAD, APR 18
Marengo CIMS Hospital launched an advanced dialysis unit for new hope and a new journey into optimized treatment options to treat patients with kidney diseases.
Dr Mohan Rajapurkar, director of Postgraduate Studies and Research at the Muljibhai Patel Urological Hospital, Nadiad who has trained 64 nephrologists who provide kidney care services in all Indian states, inaugurated this new facility on Tuesday. This new unit will be headed by one of his disciples.
- With kidney failure cases rising, it has become very urgent to cater to patients requiring dialysis with advanced technologies
- The healthcare facility celebrated the success of kidney transplants by inviting patients to an interactive get-together
- The hospital has witnessed more than 45,000 dialysis at the hospital and has conducted 54 kidney transplants to date.
- The hospital charges Rs 2,500 to Rs 2,900 per dialysis
Dr Mohan Rajapurkar said, “Post-Covid nearly 30 percent of chronic kidney patients are facing many complications while 5 percent of all Covid patients also facing kidney-related issues.”
The advanced Hemodialysis unit will function under the expert guidance of Dr Siddharth Mavani, Director, Nephrology and Kidney Transplant, Marengo CIMS Hospital, Dr. Mayur Patil, Consultant Nephrologist, Marengo CIMS Hospital, Nephrologist & Transplant physicians Dr Pankaj Shah and Dr Rechal Shah.
With a move to strengthen the existing facility for the care of kidney failure patients, the hospital has come up with a new, bigger, and better Hemodialysis unit on the premises of the healthcare facility. The hospital has witnessed more than 45000 dialysis at the hospital and has conducted 54 kidney transplants to date. The new center is a hospital-based unit with 12 dialysis stations and is equipped with the latest dialysis machines and RO plant. The hospital offers the round-the-clock availability of a dedicated and skilled team of nephrologists, dialysis technicians, dialysis nurses, renal dieticians, and social workers for the seamless functioning of the unit.
Dr Siddharth Mavani, Director, Nephrology and Kidney Transplant, Marengo CIMS Hospital says, “With this advanced dialysis unit we are equipped to expand the scope of services in Renal care. The services we offer are Hemodialysis, Maintenance HD, Dialysis in critically ill ICU patients- SLED (sustained low-efficiency dialysis), SCUF (slow continuous ultrafiltration), CRRT (continuous renal replacement therapy), Dialysis in poisoning cases, Peritoneal dialysis and Plasmapheresis. Our goal is to combine medical expertise and modern equipment to provide comprehensive kidney care services for patients with end-stage kidney disease.”
Dr. Mayur Patil, Consultant Nephrologist, Marengo CIMS Hospital says, “Chronic kidney diseases (CKD) causes people to lose their kidney function over time. Studies reveal that nearly 12 million Indians are affected by CKD or end-stage kidney failure every year. This condition requires a kidney transplant or regular dialysis treatment for a lifetime for the patient. Dialysis, also known as an artificial kidney, functions as regular kidneys by cleansing the blood by removing waste and excess water. The demand for dialysis is increasing rapidly because of increasing numbers of unregulated diabetes and hypertension, as well as increased awareness of CKD and treatment options.”
Dr Keyur Parikh, Chairman – Marengo CIMS Hospital says, “We are recognized as a preferred destination for Organ Transplants, All Cardiac interventions, Cancer, Neurological and Orthopedic interventions. The past decade has tracked the fast emergence of newer technologies that can lead to major breakthroughs. These technologies are poised to become increasingly available and accessible to patient data at lower costs, making treatment increasingly affordable. With fast-recognized symptoms of kidney health, correct diagnosis, and available technologies, CKD has emerged as a fast-addressed medical condition today. We continue to do good work to save more and more lives and keep the trust and confidence in our patients our utmost responsibility.”
The global dialysis population is growing rapidly, especially in low-income and middle-income countries; however, worldwide, a substantial number of people lack access to kidney replacement therapy, and millions of people die of kidney failure each year, often without supportive care. Patients on dialysis continue to bear a high burden of disease, shortened life expectancy, and report a high symptom burden and a low health-related quality of life. Patients, payors, regulators, and health-care systems increasingly demand improved value in dialysis care, which can only come about through true patient-centred innovation. Recent advances in biomedical research and novel technologies have created opportunities to study kidney disease in a variety of platforms, applied to human populations. Artificial wearable kidneys, Xeno transplant which is extracting a kidney from animals, and transplantation in humans also form components of a brighter future in kidney care.
